IEP vs NBIX · rev $5.18B vs P/E 45, rev $1.77B
Icahn Enterprises LP (IEP) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Icahn Enterprises LP (IEP) is a oil & gas refining & marketing company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IEP revenue for 2026-06-30 was $5.18B. Net income was -$814.0M. IEP currently screens at market cap $4.90B.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
IEP currently screens at market cap $4.90B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the IEP and NBIX stock pages for the full models.
Not investment advice.